Innoviva revives Lyndra's long-acting oral drug platform

Bob Langer (L) and Janet Woodcock June 18, 2026 08:00 AM EDT Startups In­no­vi­va re­vives Lyn­dra's long-act­ing oral drug plat­form, with Langer and Wood­cock as ad­vi­sors Kyle LaHucik Biotech Correspondent A health­care as­set and roy­al­ties hold­ing com­pa­ny is bring­ing a long-act­ing oral med­i­cine ap­proach back to life, res­ur­rect­ing a drug de­liv­ery plat­form that had ac­cu­mu­lat­ed … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER